From filling in voter information gaps to catching improprieties, the media has helped keep elections fair and transparent Our knowledge and awareness of the world today is largely determined by what the media decides to inform us. The priorities that the media sets often become the priorities of the public. In our country, the executive, the legislature and the judiciary are strongly complemented by the media. No one could vouch for...

It is said that only God and a few good men and women run India. One such man is P H Kurien. For readers unfamiliar with his name, Kurien was India's Controller General of Patents, Designs & Trade Marks until March 12, 2012. On March 9, 2012, just three days before he left office, he issued the first-ever compulsory licence in India for the manufacture of a drug still under patent....

India has achieved a major victory at the just concluded 65th World Health Assembly as it managed to push through a resolution on mental health, asking member-states to acknowledge the need for a comprehensive, coordinated response to addressing mental disorders from health and social sectors at the country level. The delegates recognised these measures which include programmes to reduce stigma and discrimination, reintegration of patients into workplace and society, support...

Those who violate ban may be fined up to Rs 5 lakh or imprisoned up to six years After Madhya Pradesh, Kerala has now become the second state in India to ban all forms of chewing tobacco products. The state has banned the manufacture, storage, distribution and sale of gutkha and pan masala, containing tobacco and nicotine, of all brands available in the market. The ban is effective from May 25. Like Madhya...

German drugmaker Bayer AG has demanded the withdrawal of the country's first compulsory licence given to Natco Pharma, arguing that a three-fourth reduction in the price of the anti-cancer drug by another Indian firm has made the permit redundant and its patent itself is vulnerable to being revoked. In March, India allowed Natco Pharma to legally make and sell a low-cost version of cancer drug Nexavar at 3% of the original...